It's getting harder and harder to disentangle the medical profession from financial conflicts of interest, a New York Times editorial says. According to the newspaper, any doctor who has inside information about clinical trials or the FDA's thinking should not do consulting work for investment firms.
Full Story (subscription):
http://www.nytimes.com/2005/08/17/opinion/17wed2.html